Nativ O, Winkler H Z, Reiman H M, Lieber M M
Department of Urology, Mayo Clinic, Rochester, Minnesota.
J Urol. 1990 Jul;144(1):23-6. doi: 10.1016/s0022-5347(17)39355-2.
From 1944 to 1987, 28 patients with squamous cell carcinoma of the upper urinary tract were treated and also had tumor specimens that were fully evaluable by flow cytometric nuclear deoxyribonucleic acid ploidy analysis: 22 had squamous cell carcinoma of the intrarenal collecting system, 4 had tumors of the ureter, and 2 had tumors of the renal pelvis and ureter. Eight patients (29%) had deoxyribonucleic acid diploid, 11 (39%) tetraploid and 9 (32%) aneuploid ploidy patterns. Ploidy pattern significantly correlated with histological grade and tumor stage. Almost all tumors were histologically of high grade; among the patients with high grade tumors ploidy analysis separated fair and poor prognosis groups. Pathological stage was the dominant clinical variable. A total of 14 patients (50%) had advanced stage disease and all died within 12 months of diagnosis. Nearly all of these patients showed abnormal ploidy patterns and ploidy analysis was not useful prognostically for this group. In contrast, all 3 patients with squamous cell carcinoma of the renal pelvis who were long-term survivors had deoxyribonucleic acid diploid tumors. However, there is no clear statistical evidence from this study that ploidy analysis provides important prognostic information independent of stage and grade for patients with squamous cell carcinoma of the renal pelvis.
1944年至1987年,对28例上尿路鳞状细胞癌患者进行了治疗,并且这些患者还拥有可通过流式细胞术核脱氧核糖核酸倍体分析进行全面评估的肿瘤标本:22例为肾内集合系统鳞状细胞癌,4例为输尿管肿瘤,2例为肾盂和输尿管肿瘤。8例患者(29%)为脱氧核糖核酸二倍体,11例(39%)为四倍体,9例(32%)为非整倍体倍体模式。倍体模式与组织学分级和肿瘤分期显著相关。几乎所有肿瘤在组织学上均为高级别;在高级别肿瘤患者中,倍体分析区分出了预后良好和不良的组。病理分期是主要的临床变量。共有14例患者(50%)患有晚期疾病,所有患者均在诊断后12个月内死亡。几乎所有这些患者均表现出异常的倍体模式,倍体分析对该组患者的预后没有帮助。相比之下,3例肾盂鳞状细胞癌长期存活患者均患有脱氧核糖核酸二倍体肿瘤。然而,这项研究没有明确的统计证据表明倍体分析能为肾盂鳞状细胞癌患者提供独立于分期和分级的重要预后信息。